Seeking Alpha

A Delaware court has upheld two patents in favor of Pronova's heart drug Lovaza, ruling against...

A Delaware court has upheld two patents in favor of Pronova's heart drug Lovaza, ruling against Par Pharmaceutical (PRX) and Teva Pharmaceutical (TEVA). The ruling prevents Par and Teva from selling generic versions of Lovaza, which lowers very high levels of triglycerides in the bloodstream.
Comments (4)
  • I wonder if all the pro-TEVA bloggers here will try to spin this news along with the Lipitor 'decision" into something that makes TEVA a "buy"!!!
    29 May 2012, 08:37 PM Reply Like
  • It's the biggest gainer on my list right now today :)
    30 May 2012, 01:37 PM Reply Like
  • If I understand well that it is an approval for two medicines than Teva shall certainly go higher.
    30 May 2012, 06:24 AM Reply Like
  • it is a buy
    30 May 2012, 11:01 AM Reply Like
DJIA (DIA) S&P 500 (SPY)